Relationship between neutralizing and opsonizing monoclonal antibodies against foot-and-mouth disease virus.

FMDV Fc gamma receptors antibodies monoclonal antibody opsonization

Journal

Frontiers in veterinary science
ISSN: 2297-1769
Titre abrégé: Front Vet Sci
Pays: Switzerland
ID NLM: 101666658

Informations de publication

Date de publication:
2022
Historique:
received: 31 08 2022
accepted: 26 09 2022
entrez: 31 10 2022
pubmed: 1 11 2022
medline: 1 11 2022
Statut: epublish

Résumé

Previous studies demonstrated that polyclonal antibodies against foot-and-mouth disease virus (FMDV) generated by vaccination can mediate immune functions not only through virus neutralization but also through promoting virus uptake by macrophages and dendritic cells that are otherwise resistant to FMDV infection. This causes abortive infections resulting in activation, enhanced antigen presentation but also cell death. Here we report the use of RAW264.7 cells representing a murine macrophage cells line to characterize opsonizing functions of a collection of monoclonal antibodies (mAbs) against FMDV O and A serotypes. We demonstrate that all neutralizing immunoglobulin G isotype mAbs are able to opsonize FMDV resulting in increased cell death of RAW264.7 cells. In contrast, neutralizing IgM antibodies did not possess this activity. Opsonization was observed with broader reactivity within the serotype when compared to neutralization. Importantly, the anti-O serotype D9 mAb reacting with the continuous epitope within the G-H loop of VP1 that contains the RGD binding site of FMDV, opsonized several FMDV serotypes despite its restricted neutralizing activity within the O serotype. Furthermore, by generating RAW264.7 cells expressing bovine CD32, an easy-to-use cell-based assay system to test for bovine antibody-dependent enhanced infection of FMDV was generated and tested with a collection of sera. The data indicate that opsonizing titers correlated better with vaccine dose when compared to neutralizing titers. On the other hand, neutralization and opsonization titers were similar predictive of protection. We conclude that low avidity interactions are sufficient to mediate Fcγ receptor-mediated immune functions that could contribute to protective immune responses against FMDV.

Identifiants

pubmed: 36311653
doi: 10.3389/fvets.2022.1033276
pmc: PMC9597200
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1033276

Informations de copyright

Copyright © 2022 Summerfield, Gerber, Schmitt, Liniger, Grazioli and Brocchi.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Vet Res. 2012 Aug 30;43:64
pubmed: 22934974
J Virol. 2011 Mar;85(5):2212-23
pubmed: 21177807
J Virol Methods. 2011 Aug;175(2):253-60
pubmed: 21635921
Virology. 1987 Apr;157(2):516-25
pubmed: 2435060
J Gen Virol. 2013 Mar;94(Pt 3):559-569
pubmed: 23197575
Vaccine. 2009 Nov 5;27 Suppl 4:D90-4
pubmed: 19837296
Vaccine. 2012 Nov 6;30(48):6845-50
pubmed: 23000129
J Immunol. 2002 Jul 1;169(1):193-203
pubmed: 12077245
Immunology. 1988 Oct;65(2):187-91
pubmed: 2847979
J Virol. 1998 Dec;72(12):9873-80
pubmed: 9811723
Vaccine. 2014 Jan 16;32(4):433-6
pubmed: 24342253
EMBO J. 1982;1(7):869-74
pubmed: 6203738
Vaccine. 2019 Sep 3;37(37):5515-5524
pubmed: 31405637
Vaccine. 2001 Apr 6;19(20-22):2975-86
pubmed: 11282209
Antiviral Res. 2011 Nov;92(2):262-70
pubmed: 21878353
Clin Vaccine Immunol. 2009 Aug;16(8):1151-7
pubmed: 19553550
Rev Sci Tech. 1993 Jun;12(2):559-70
pubmed: 7691274
Methods Enzymol. 1981;73(Pt B):3-46
pubmed: 7300683
Viruses. 2021 May 31;13(6):
pubmed: 34072720
Virology. 1990 Nov;179(1):26-34
pubmed: 1699353
Vaccine. 2003 Mar 28;21(13-14):1466-77
pubmed: 12615443
Vet Microbiol. 1992 Feb;30(2-3):99-112
pubmed: 1313624
Rev Sci Tech. 1986 Jun;5(2):299-314
pubmed: 32917083
J Virol. 1992 Apr;66(4):1835-40
pubmed: 1312607
J Gen Virol. 1987 Jun;68 ( Pt 6):1637-47
pubmed: 2438378
Scand J Immunol. 1999 Aug;50(2):167-76
pubmed: 10447921
Transbound Emerg Dis. 2020 Nov;67(6):3005-3015
pubmed: 32530134
Biologicals. 1991 Oct;19(4):299-310
pubmed: 1665700
Gene Ther. 2007 May;14(10):836-44
pubmed: 17330086
J Immunol Methods. 2003 Sep;280(1-2):113-23
pubmed: 12972192
Vet Immunol Immunopathol. 1997 Sep 19;58(3-4):265-75
pubmed: 9436270

Auteurs

Artur Summerfield (A)

Institute of Virology and Immunology, Köniz, Switzerland.
Department of Infectious Diseases and Pathobiology (DIP), Vetsuisse Faculty, University of Bern, Bern, Switzerland.

Heidi Gerber (H)

Institute of Virology and Immunology, Köniz, Switzerland.

Rebeka Schmitt (R)

Institute of Virology and Immunology, Köniz, Switzerland.

Matthias Liniger (M)

Institute of Virology and Immunology, Köniz, Switzerland.

Santina Grazioli (S)

Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia-Romagna, Brescia, Italy.

Emiliana Brocchi (E)

Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia-Romagna, Brescia, Italy.

Classifications MeSH